Solid Dose Formulation Troubleshooter
Diagnose solid dose formulation failures and optimize excipient strategies
What You Can Do
You can rapidly diagnose why your solid dose formulations are failing—whether due to poor flowability, insufficient hardness, moisture sensitivity, dissolution issues, or API degradation. The skill walks you through structured root-cause analysis, maps chemical interactions between your drug substance and excipients across pH, temperature, and moisture conditions, then prioritizes excipient replacements based on regulatory precedent and manufacturing feasibility. You'll document all decisions with clear rationale ready for CMC submissions.
Features
Evaluate drug-excipient interactions across storage conditions, pH ranges, and moisture levels to predict degradation pathways and incompatibilities
Systematically identify whether issues stem from flowability, compressibility, moisture uptake, dissolution kinetics, or API stability
Receive prioritized replacement candidates based on pharmaceutical precedent, regulatory acceptance, and manufacturing feasibility
Assess segregation, blending uniformity, compression challenges, and process robustness before pilot batches
Generate justified excipient selections and test rationales ready for regulatory submissions and change controls
Anticipate moisture uptake, API degradation, and long-term shelf-life risks for proposed formulation changes
Evaluate compatibility impacts when switching excipient sources or grades to inform risk assessments
Example Output
Example 1: Moisture Sensitivity Issue
Input: Tablet hardness dropping after 3 months at 25°C/60% RH; API is hygroscopic
Output:
- Root Cause: Microcrystalline cellulose (Avicel PH101) absorbing moisture, softening tablet matrix
- Recommended Swaps: Low-substitution hypromellose (HPMC) or pregelatinized starch; reduce MCC to 15–20%
- Testing Priority: DVS (dynamic vapor sorption) on reformulated blend; accelerated 25°C/75% RH for 3 months
- CMC Rationale: HPMC precedent in 500+ approved tablets; lower moisture equilibrium at shelf conditions
Example 2: Poor Flowability in High-Speed Tableting
Input: Weight variation exceeding ±7.5%; die filling inconsistent at 100 tablets/min
Output:
- Root Cause: Magnesium stearate (1% w/w) over-lubricated, reducing particle friction; API needle crystals jamming hopper
- Optimization Steps: Reduce lubricant to 0.5%, add colloidal silicon dioxide (2%) for flow aid; consider spheronized API or wet-milled batch
- Manufacturing Controls: Angle of repose <35°, Hausner ratio <1.25; validate at target speed
- Stability Impact: No expected change; confirm dissolution remains >85% at 30 min
Example 3: Excipient Supplier Qualification
Input: Primary supplier of croscarmellose sodium unavailable; need to qualify alternative grade
Output:
- Compatibility Check: Cross-reactivity screening vs. current binder/disintegrant blend; moisture content specification alignment
- Risk Assessment: Medium risk if substitution grade has different particle size; low risk if spec-equivalent
- Validation Plan: 3-tablet dissolution profiles, hardness, friability, and 1-month stability at accelerated conditions
- Regulatory Path: Document as supplier change via Type C variation or annual report depending on jurisdiction
What's Included
- SKILL.md: Complete skill instruction file with structured decision workflows
- Excipient Compatibility Assessment Template: Systematic checklist for drug-excipient interaction evaluation across pH, temperature, and moisture
- Formulation Failure Diagnosis Flowchart: Decision tree to isolate root causes (flowability, hardness, dissolution, stability)
- Excipient Replacement Priority Matrix: Framework to rank candidate excipients by regulatory precedent, cost, and manufacturability
- CMC Documentation Checklist: Rationale templates for regulatory submissions justifying excipient selections and change controls
Who It's For
- Formulation Scientists — optimizing solid dose designs during mid-to-late-stage development and troubleshooting batch failures
- Process Engineers — assessing manufacturability impacts of formulation changes and predicting scale-up risks
- Quality Assurance & CMC Specialists — documenting excipient justifications and change controls for regulatory submissions
- Regulatory Affairs Teams — building evidence packages for supplier changes, excipient substitutions, and manufacturing variations
- Contract Manufacturers — rapidly qualifying alternative formulations when excipient availability or cost pressures emerge
Best For
- Diagnosing why tablets/capsules are failing in-process or stability testing
- Evaluating excipient swaps due to supplier changes, cost reduction, or availability constraints
- Optimizing formulations for manufacturability (flowability, compressibility, blending uniformity)
- Building CMC sections with justified excipient selections and compatibility data
- Predicting moisture sensitivity, dissolution, and API degradation risks before scale-up
You might also like
You can submit tool designs—drawings, specifications, or descriptions—and Claude will evaluate manufacturability constraints, identify potential failure modes using structured frameworks, and recommend cost-reduction opportunities. You'll receive a prioritized report covering structural analysis, production feasibility, material efficiency, and design trade-offs.
by kody-w
You can automate the validation of clinical trial data against protocol specifications, identify discrepancies including missing values, out-of-range results, protocol violations, and CRF inconsistencies. The skill generates audit-ready query documentation, categorizes anomalies by severity and type, resolves root causes systematically, and produces FDA inspection-ready reports that trace every data decision and corrective action for CDISC and regulatory submission.
by kody-w
You can submit raw mass spectrometry observations, instrument parameters, or sample preparation details to Claude and receive targeted diagnostic frameworks that explain anomalous results. Claude systematically generates plausible mechanistic explanations for unexpected protein abundance patterns, quantification inconsistencies, and PTM findings—then helps you design minimal, hypothesis-driven troubleshooting experiments to test them.
by kody-w
You can take unstructured monitoring visit observations and convert them into formal, audit-ready reports that categorize findings by risk level (Critical, Major, Minor), validate protocol compliance, and generate actionable follow-up items with assigned owners and resolution dates. The skill ensures your documentation meets FDA inspection standards and ICH-GCP requirements while creating clear escalation pathways for high-risk issues.
by kody-w
You can validate eCRF and paper CRF datasets against protocol-defined rules, automatically identify data discrepancies (missing fields, out-of-range values, date inconsistencies), generate structured Data Query Forms (DQFs) for site clarification, track resolution status, and create audit-ready compliance documentation that meets FDA 21 CFR Part 11 and GCP requirements. This workflow reduces manual validation time while ensuring 100% traceability and regulatory readiness for inspections.
by kody-w
Get comprehensive PCB design analysis covering power delivery networks, signal integrity, thermal management, and manufacturing constraints. Claude identifies potential issues early and provides specific, actionable optimization recommendations to reduce cost, improve reliability, and accelerate time-to-market. Suitable for designs from initial concept through production-ready layouts.
by kody-w
You consolidate parallel data streams from preclinical toxicology studies (clinical pathology, histopathology, body weight changes, organ weights, clinical observations, mortality) into coherent regulatory-compliant narratives. This skill synthesizes findings across 6–12 endpoints simultaneously, identifies NOAEL/LOAEL with biological justification, determines safety margins, interprets species-specific or sex-specific signals, and produces Results & Discussion sections that satisfy FDA/EMA reviewers while supporting appropriate dosing decisions for IND-enabling studies.
by kody-w
This skill systematically analyzes your product designs to identify manufacturability issues early, saving costly revisions and manufacturing delays. It evaluates geometry, material selection, tolerances, assembly feasibility, and production process constraints. You get actionable feedback on cost drivers, process risks, and design optimizations before committing to production.
by kody-w